ST18
Basic information
Region (hg38): 8:52110838-52460959
Previous symbols: [ "ZNF387" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ST18 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 53 | 59 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 53 | 4 | 3 |
Variants in ST18
This is a list of pathogenic ClinVar variants found in the ST18 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-52113208-A-C | not specified | Uncertain significance (Nov 03, 2023) | ||
8-52116294-T-C | not specified | Uncertain significance (Sep 26, 2022) | ||
8-52116315-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
8-52116382-C-G | not specified | Uncertain significance (Feb 08, 2023) | ||
8-52118363-G-T | Benign (Jun 26, 2018) | |||
8-52131961-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
8-52131992-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
8-52132022-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
8-52132038-G-C | not specified | Uncertain significance (Dec 09, 2023) | ||
8-52132103-G-A | not specified | Uncertain significance (May 20, 2024) | ||
8-52132105-C-T | not specified | Uncertain significance (Sep 15, 2021) | ||
8-52133085-T-C | not specified | Uncertain significance (Aug 01, 2023) | ||
8-52133120-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
8-52133288-C-T | not specified | Uncertain significance (May 05, 2023) | ||
8-52137434-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
8-52142960-T-A | not specified | Uncertain significance (May 30, 2023) | ||
8-52142990-G-T | not specified | Uncertain significance (Dec 20, 2021) | ||
8-52143011-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
8-52149755-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
8-52149814-T-C | not specified | Uncertain significance (Oct 26, 2021) | ||
8-52149815-A-G | not specified | Uncertain significance (Jan 27, 2022) | ||
8-52149832-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
8-52149835-A-G | Benign (Aug 15, 2018) | |||
8-52149845-T-C | not specified | Uncertain significance (Aug 16, 2021) | ||
8-52149911-C-T | not specified | Uncertain significance (Jul 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ST18 | protein_coding | protein_coding | ENST00000276480 | 20 | 350121 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.995 | 0.00541 | 125735 | 0 | 12 | 125747 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.246 | 559 | 576 | 0.971 | 0.0000300 | 6950 |
Missense in Polyphen | 196 | 229.37 | 0.85453 | 2737 | ||
Synonymous | -0.336 | 219 | 213 | 1.03 | 0.0000119 | 1977 |
Loss of Function | 5.56 | 8 | 50.8 | 0.158 | 0.00000281 | 611 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000442 | 0.0000439 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000670 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Repressor that binds to DNA sequences containing a bipartite element consisting of a direct repeat of the sequence 5'-AAAGTTT-3' separated by 2-9 nucleotides. Represses basal transcription activity from target promoters (By similarity). Inhibits colony formation in cultured breast cancer cells. {ECO:0000250, ECO:0000269|PubMed:15489893}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.310
- rvis_EVS
- -0.61
- rvis_percentile_EVS
- 17.5
Haploinsufficiency Scores
- pHI
- 0.471
- hipred
- N
- hipred_score
- 0.477
- ghis
- 0.561
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- St18
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;negative regulation of cell population proliferation;tumor necrosis factor-mediated signaling pathway;positive regulation of transcription by RNA polymerase II;interleukin-6-mediated signaling pathway;interleukin-1-mediated signaling pathway;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway
- Cellular component
- nucleus;protein-DNA complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;zinc ion binding